Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.64 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.60 |
| ▸ | F3 | P13726 | 2/20 | 0.57 |
| ▸ | MAOB | P27338 | 5/20 | 0.57 |
| ▸ | KRAS | P01116 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | TNFRSF1A | P19438 | 2/20 | 0.54 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.54 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.54 |
| ▸ | BCHE | P06276 | 1/20 | 0.53 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.52 |
| ▸ | TUBB | P07437 | 1/20 | 0.52 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.52 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12879519 | 0.90 | CYP1B1 (0.66) | CYP1B1CYP1A1CYP1A2CYP2D6ABCG2 | |
| SCHEMBL9927113 | 0.85 | ABCG2 (0.59) | CYP1B1CYP1A1CYP1A2CYP2D6ABCG2 | |
| SCHEMBL9112460 | 0.82 | MAPT (0.75) | CYP1B1CYP1A1CYP1A2CYP2D6ABCG2 | |
| SCHEMBL9112457 | 0.82 | MAPT (0.75) | CYP1B1CYP1A1CYP1A2CYP2D6ABCG2 | |
| SCHEMBL8987059 | 0.81 | BCHE (0.78) | CYP1B1CYP1A1CYP1A2CYP2D6ABCG2 | |
| SCHEMBL8987057 | 0.81 | BCHE (0.78) | CYP1B1CYP1A1CYP1A2CYP2D6ABCG2 | |
| SCHEMBL9927124 | 0.81 | TUBB4A (0.78) | CYP1B1CYP1A1CYP1A2ABCG2MAPT | |
| SCHEMBL7194847 | 0.79 | MAOB (0.77) | CYP1B1CYP1A1CYP1A2CYP2D6ABCG2 | |
| SCHEMBL7194845 | 0.79 | MAOB (0.77) | CYP1B1CYP1A1CYP1A2CYP2D6ABCG2 | |
| SCHEMBL12879513 | 0.78 | ABCG2 (0.60) | CYP1B1CYP1A1CYP1A2CYP2D6ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160166592-A1 | BORONIC ACID DERIVATIVES OF RESVERATROL FOR ACTIVATING DEACETYLASE ENZYMES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-06-16 | — | — | US | disclosed |
| US-20120149663-A1 | BORONIC ACID COMPOSITIONS AND METHODS RELATED TO CANCER | GEORGETOWN UNIVERSITY (US) | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160166592-A1 | BORONIC ACID DERIVATIVES OF RESVERATROL FOR ACTIVATING DEACETYLASE ENZYMES | HDAC1, BRDT, HDAC7 | CYP1B1 1032/4885CYP1A1 1998/4885CYP1A2 2832/4885 |
| US-20120149663-A1 | BORONIC ACID COMPOSITIONS AND METHODS RELATED TO CANCER | RB1, RBBP5, CCNB1 | CYP1B1 1883/4885CYP1A1 2869/4885CYP1A2 4053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.